Amsurg Corp. (AMSG) Stock Price Up 2.9%
Amsurg Corp. (NASDAQ:AMSG)’s share price rose 2.9% during trading on Monday . The company traded as high as $65.58 and last traded at $65.44, with a volume of 611,493 shares traded. The stock had previously closed at $63.60.
AMSG has been the subject of a number of analyst reports. Mizuho upped their price objective on shares of Amsurg Corp. from $90.00 to $95.00 and gave the stock a “buy” rating in a research report on Friday, June 24th. Citigroup Inc. downgraded shares of Amsurg Corp. from a “buy” rating to a “neutral” rating in a research report on Thursday, June 16th. Zacks Investment Research downgraded shares of Amsurg Corp. from a “buy” rating to a “hold” rating in a research report on Friday, August 5th. Barclays PLC initiated coverage on shares of Amsurg Corp. in a research report on Wednesday, June 1st. They set an “equal weight” rating and a $85.00 price objective for the company. Finally, Jefferies Group restated a “buy” rating on shares of Amsurg Corp. in a research report on Sunday, July 3rd. Four research analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company. The stock has an average rating of “Buy” and an average target price of $93.91.
The company has a market cap of $3.50 billion and a price-to-earnings ratio of 19.32. The firm has a 50-day moving average price of $71.81 and a 200-day moving average price of $74.04.
Amsurg Corp. (NASDAQ:AMSG) last released its quarterly earnings results on Tuesday, August 2nd. The company reported $1.10 earnings per share for the quarter, topping analysts’ consensus estimates of $1.08 by $0.02. During the same period in the previous year, the business posted $0.97 EPS. The company had revenue of $758.50 million for the quarter, compared to analyst estimates of $769.88 million. The firm’s quarterly revenue was up 21.5% compared to the same quarter last year. Equities analysts predict that Amsurg Corp. will post $4.33 earnings per share for the current year.
In other news, insider Robert Jon Coward sold 7,500 shares of the firm’s stock in a transaction that occurred on Thursday, August 18th. The shares were sold at an average price of $64.36, for a total transaction of $482,700.00. Following the completion of the sale, the insider now owns 105,007 shares of the company’s stock, valued at $6,758,250.52. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.
An institutional investor recently raised its position in Amsurg Corp. stock. Dimensional Fund Advisors LP raised its position in Amsurg Corp. (NASDAQ:AMSG) by 3.2% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 2,994,029 shares of the company’s stock after buying an additional 92,088 shares during the period. Dimensional Fund Advisors LP owned about 6.27% of Amsurg Corp. worth $227,552,000 at the end of the most recent reporting period.
AmSurg Corp. is a surgical center and physician services company. The Company is an owner and operator of ambulatory surgery centers (ASCs) in the United States. The Company is also a provider of outsourced physician services in the areas of anesthesiology, children’s services, emergency medicine and radiology.
Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.